Attendees who purchased access to the 2016 Annual Meeting webcast were sent login information on May 11, 2016.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 4 records per page: next > | last >>
pages: 1 2 3 4 presentations: 1 to 25 of 81
Using Tumor Biology to Drive More Effective Sarcoma Therapy
Overview
Christopher T Denny
University of California, Los Angeles, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Using Tumor Biology to Drive More Effective Sarcoma Therapy
New insights into sarcoma metastasis--opportunities for therapeutic intervention
Poul H.B. Sorensen
Univ. of British Columbia, Vancouver, BC, Canada
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Using Tumor Biology to Drive More Effective Sarcoma Therapy
Are we smart enough to cure sarcoma yet? Ewing sarcoma as a paradigm
Stephen L Lessnick
Nationwide Children's Hosp. Ctr. for Childhood Cancer, Columbus, OH, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Using Tumor Biology to Drive More Effective Sarcoma Therapy
Immunotherapies for Sarcoma: Progress and Challenges
Crystal L. Mackall
Stanford Univ. School of Medicine, Stanford, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
The Pediatric Cancer Genome
Acute lymphoblastic leukemia
Charles G. Mullighan
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
The Pediatric Cancer Genome
Credentialing genomic medicine in pediatric oncology: Neuroblastoma as a model
Yael P. Mosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
The Pediatric Cancer Genome
Pediatric and adult high grade gliomas: A tale of a histone tail
Nada Jabado
McGill University Department of Pediatrics, Montreal, QC, Canada
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
p53-Dependent and -Independent Roles of Mdm2 in Cancer Cells and Human Disease
Invited Speaker
Carol L. Prives
Columbia University, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 7:00 AM-8:00 AM
The Treatment of Advanced Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors
Chairperson and Introduction
Patrick Schoffski
Catholic Univ. of Leuven Cancer Inst., Leuven, Belgium
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:00 PM
The Treatment of Advanced Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors
Emerging first line systemic treatment options for advanced soft tissue sarcoma
William Tap
MSKCC, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:00 PM
The Treatment of Advanced Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors
New evidence-based treatment standards for advanced inoperable leiomyo- and liposarcomas after failure of first-line chemotherapy
Patrick Schoffski
Catholic Univ. of Leuven Cancer Inst., Leuven, Belgium
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:00 PM
The Treatment of Advanced Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors
Experimental treatment options for gastrointestinal stromal tumors with primary or secondary resistance to tyrosine kinase inhibitors
Suzanne George
Dana Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:00 PM
The Treatment of Advanced Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors
Clinical genomic testing in sarcoma for risk stratification, treatment selection, and disease monitoring
Marc Ladanyi
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 2:15 PM-4:00 PM
Drugging the Cell Cycle
Chairperson
Norman E. Sharpless
UNC Lineberger Comp. Cancer Center, Chapel Hill, NC, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
Drugging the Cell Cycle
Mechanisms of action of the CDK4 and CDK6 inhibitor abemaciclib: Single-agent and combination activities in preclinical models for human cancer
Richard Beckmann
Eli Lilly and Company, Indianapolis, IN, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
Drugging the Cell Cycle
Mitosis-independent actions of anti-microtubule drugs
Timothy J. Mitchison
Harvard Medical School, Boston, MA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
Drugging the Cell Cycle
Use of the WEE1 inhibitor AZD1775 to exploit replication stress in cancers
Mark J O'Connor
AstraZeneca, Cheshire, United Kingdom
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
Should Tumor Heterogeneity Guide Therapy?
Invited speaker
Richard M. Marais
Cancer Research UK Manchester Institute, Manchester, United Kingdom
from AACR Annual Meeting 2016 on April 18, 2016 5:00 PM-6:30 PM
Should Tumor Heterogeneity Guide Therapy?
Invited Speaker
David B. Solit
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 18, 2016 5:00 PM-6:30 PM
Immunotherapy for Childhood Malignancies
Invited speaker
Crystal L. Mackall
Stanford University School of Medicine, Palo Alto, CA, United States
from AACR Annual Meeting 2016 on April 19, 2016 7:00 AM-8:00 AM
The Mechanism of Chromothripsis
Patterns and incidence of chromothripsis across cancers
Peter J. Campbell
Wellcome Trust Sanger Inst., Cambridge, United Kingdom
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
The Mechanism of Chromothripsis
Generation of chromothripsis events in a cell-based system
Jan Korbel
European Molecular Biology Laboratory, Heidelberg, Germany
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
The Mechanism of Chromothripsis
Chromosome rearrangements that arise as a consequence of mitotic errors
René H. Medema
Netherlands Cancer Institute, Amsterdam, Netherlands
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
The Mechanism of Chromothripsis
Chromothripsis from DNA damage in micronuclei
David Pellman
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2015 on April 18, 2015 8:00 AM-10:00 AM
Biomarkers for Solid Tumors in a Post-TCGA World
The impact of intra- and inter-tumour genetic heterogeneity on the development of biomarkers
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2015 on April 18, 2015 10:15 AM-12:15 PM
<< first | < prev page: of 4 records per page: next > | last >>
pages: 1 2 3 4 presentations: 1 to 25 of 81